MFS
SCMP

MSI Financial Services’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

MSI Financial Services’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$819K Buy
+60,461
New +$843K 0.03% 515
2016
Q1 		– Sell
-50
Closed -$1K – 4189
2015
Q4 		$1K Buy
+50
New +$896 ﹤0.01% 3768

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

MSI Financial Services's SCMP Position: Q4 2016 in Review

MSI Financial Services opened a new position in Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2016: 60,461 shares worth $819K. The stake represents 0.03% of the portfolio and ranks #515 among its holdings. This is a return to the name: MSI Financial Services previously reported a position in SCMP as recently as Q4 2015.

MSI Financial Services first reported a position in SCMP in Q4 2015 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

  • MSI Financial Services held 60,461 shares of Sucampo Pharmaceuticals, Inc. worth $819K as of Q4 2016.
  • Sucampo Pharmaceuticals, Inc. was a new MSI Financial Services position in Q4 2016.
  • Sucampo Pharmaceuticals, Inc. made up 0.03% of MSI Financial Services's portfolio in Q4 2016, its #515 holding.
  • MSI Financial Services first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.